Partial arterial carbon dioxide and oxygen pressure in patients with cardiogenic shock

• Verfasst von: Rusnak, Jonas [VerfasserIn]
• Verfasst von: Schupp, Tobias [VerfasserIn]
• Verfasst von: Weidner, Kathrin [VerfasserIn]
• Verfasst von: Ruka, Marinela [VerfasserIn]
• Verfasst von: Egner-Walter, Sascha [VerfasserIn]
• Verfasst von: Schmitt, Alexander [VerfasserIn]
• Verfasst von: Akın, Muharrem [VerfasserIn]
• Verfasst von: Mashayekhi, Kambis [VerfasserIn]
• Verfasst von: Ayoub, Mohamed [VerfasserIn]
• Verfasst von: Behnes, Michael [VerfasserIn]
• Verfasst von: Akın, Ibrahim [VerfasserIn]
• Titel: Partial arterial carbon dioxide and oxygen pressure in patients with cardiogenic shock
• Verf.angabe: Jonas Rusnak, Tobias Schupp, Kathrin Weidner, Marinela Ruka, Sascha Egner-Walter, Alexander Schmitt, Muharrem Akin, Kambis Mashayekhi, Mohamed Ayoub, Michael Behnes, Ibrahim Akin
• E-Jahr: 2025
• Jahr: 09 May 2025
• Umfang: 10 S.
• Illustrationen: Illustrationen
• Fussnoten: Gesehen am 27.05.2025
• Titel Quelle: Enthalten in: Internal and emergency medicine
• Ort Quelle: Milan : Springer Milan, 2006
• Jahr Quelle: 2025
• Band/Heft Quelle: (2025), Seite 1-10
• ISSN Quelle: 1970-9366
• DOI: doi:10.1007/s11739-025-03926-2
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: Acute Heart Failure
• Sach-SW: Anesthesiology
• Sach-SW: Carbon dioxide
• Sach-SW: Cardiogenic shock
• Sach-SW: Intensive Care Medicine
• Sach-SW: Mortality
• Sach-SW: Oxygen
• Sach-SW: Prognosis
• Sach-SW: Respiratory distress syndrome
• Sach-SW: Risk Factors
• Sach-SW: Ventilation
• K10plus-PPN: 192687627X

Abstract

In patients with acute cardiovascular diseases, hypocapnia, hypoxia and hyperoxia are known to be associated with increased mortality. This monocentric prospective registry study included 238 consecutive patients with cardiogenic shock (CS). The study aimed to assess the prognostic impact of partial arterial carbon dioxide (PaCO2) and oxygen pressure (PaO2) on 30-day all-cause mortality. Statistical analyses included t-tests, Spearman´s correlation, Kaplan-Meier and Cox regression analyses. No difference was found between quartiles of PaCO2 (log-rank p = 0.416) and PaO2 (log-rank p = 0.946) in the entire cohort. In the subgroup of patients with ventilation on admission, patients with PaCO2 ≤ 33 mmHg showed the highest 30-day all-cause mortality compared to the other quartiles (82.6% vs. 46.9% vs. 54.0% vs. 59.6% log-rank p = 0.026). No differences were found between levels of PaO2, when stratified by quartiles (log-rank p = 0.895). After differentiation between patients with PaCO2 ≤ 33 mmHg and PaCO2 > 33 mmHg the association with 30-day all-cause mortality remained significant (82.6% vs. 54.5% log-rank p = 0.006) in ventilated patients, whereas still no difference could be seen in the entire cohort (log-rank p = 0.264). Even after multivariable adjustment PaCO2 ≤ 33 mmHg remained an independent risk factor for 30-day all-cause mortality (HR 1.936; 95% CI 1.131-3.316; p = 0.016) in ventilated CS-patients. In conclusion, no association was found between different levels of PaCO2 and PaO2 with 30-day all-cause mortality in patients with CS. However, in the subgroup of CS-patients requiring ventilation, PaCO2 ≤ 33 mmHg was associated with an increased 30-day all-cause mortality.